Oncoclínicas saw its Q2 2026 net loss more than triple to R$475.7 million (about US$91 million) as revenue fell and drug shortages hit its cancer clinics.
Brazil · Earnings
Key Facts
—The loss Oncoclínicas lost R$475.7 million (about US$91 million) in Q2 2026, roughly 3.3 times the R$142.3 million loss a year earlier.
—The revenue Net revenue fell 28.5% to R$1.047 billion (around US$201 million), while gross revenue dropped 25.9% to R$1.227 billion.
—The cause Drug shortages at its clinics cut gross sales by about R$430 million, and higher bad-debt provisions squeezed the rest.
Receita líquida da rede de tratamento para câncer teve queda de 28,5%, entre abril e junho, somando R$ 1 bilhão
Prejuízo disparou para R$ 438,7 milhões; receita líquida caiu 22,3%
Rede de tratamento oncológico passa por processo de reestruturação extrajudicial
Oncoclínicas sold its Saudi oncology venture for US$6.5 million, a small divestment that signals a wider deleveraging push at the…
Rede de clínicas oncológicas vive crise financeira há meses. Cenário já fez tratamentos de pacientes de planos de saúde ser
Brazil cancer network Oncoclinicas seeks 40–50% creditor write-off on $640M debt, with $85M Q1 loss and $84M cash trapped at…
